GSK Teams Up with Ali Health to Promote HPV Vaccine in China

23:42 EDT 24 Aug 2017 | ChinaBio Today

GlaxoSmithKline China will partner with Ali Health to promote Cervarix, its HPV/cervical cancer vaccine in China. Ali Health, a part of Alibaba's on-line shopping program Taobao, will feature information on the vaccine and provide links to China community health clinics for consultations and appointments. GSK and Ali Health hope to have 1500 clinics in 100 China cities signed up with the website by the end of the year. Eventually, the two companies plan to extend the on-line partnership to include GSK's pediatric and adult vaccines. More details....

Stock Symbol: (NYSE: GSK)

Share this with colleagues:

Original Article: GSK Teams Up with Ali Health to Promote HPV Vaccine in China


More From BioPortfolio on "GSK Teams Up with Ali Health to Promote HPV Vaccine in China"

Quick Search


Relevant Topics

GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Human Papillomavirus (HPV)
Human papilloma viruses (HPV) affect the skin and the moist membranes lining your body, for example, in your cervix, anus, mouth and throat. HPV is a common and highly contagious infection, with over three quarters of sexually active women acquiring it ...